Dr Reddy's rises 2% on deal to acquire Eton Pharma’s portfolio Dr. Reddy's has acquired a portfolio of injectable products from Eton Pharma for an upfront payment of $5 million in cash, plus contingent payments of up to $45 million By Chitranjan Kumar
